Research programme: taxane derivatives - Indena
Alternative Names: IDN 5390; IDN 6140Latest Information Update: 04 Nov 2017
At a glance
- Originator Indena
- Class Paclitaxels; Taxanes
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in Italy (IV)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in Italy (PO)
- 24 Oct 2008 Pharmacodynamics data from a preclinical trial in glioma presented at the 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (EORTC-NCI-AACR-2008)